Immunodiagnostic Systems in collaboration with Diagnostica Stago

Immunodiagnostic Systems (IDS), which produces manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has unveiled what it described as a 'significant collaboration' with Diagnostica Stago, a French-based producer of coagulation and haemostasis diagnostic kits and instrumentation.

Immunodiagnostic Systems (IDS), which produces manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, has unveiled what it described as a 'significant collaboration' with Diagnostica Stago, a French-based producer of coagulation and haemostasis diagnostic kits and instrumentation.

Following a successful feasibility project, IDS and Stago have established a collaboration partnership that will assist Stago in developing coagulation and haemostasis assays for use on the IDS-iSYS immunoanalyzer.

As part of this collaboration, Stago has also agreed to help fund IDS' development of the IDS-iSYS mark II instrument and eventually deploy it in their fields of expertise.

IDS will be paid €3.5m in a series of milestone payments and Stago will also contribute €1.0m to the development of the IDS-iSYS mark II.

Both programmes are expected to take between two and three years to complete.

IDS said it also expects to earn revenues from the sale of instruments, ancillary products and royalties.

Patrik Dahlen, Chief Executive Officer of IDS, said: "Our collaboration with Stago reinforces our belief that the IDS-iSYS platform is one of the leading technologies in the field of specialty diagnostics. Stago is an excellent company with a great reputation in its areas of expertise and shares IDS' values of delivering high quality tests to the specialty IVD market. We look forward to working with Stago in the development of our respective next generation instrumentation platforms."

The share price rose 4.89% to 295p by 14:40.

NR

Recommended

Three sustainable stocks that are doing well by doing good
Share tips

Three sustainable stocks that are doing well by doing good

Professional investor Peter Michaelis of the Liontrust Sustainable Investment Team picks three stocks to buy that are helping to create a cleaner, saf…
26 Jul 2021
Share tips of the week – 23 July
Share tips

Share tips of the week – 23 July

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
23 Jul 2021
Will Zoom’s $15bn purchase help it expand?
Tech stocks

Will Zoom’s $15bn purchase help it expand?

The videoconferencing platform became a household name during the pandemic, but it now needs new sources of growth. Alex Rankine reports
23 Jul 2021
Philip Morris goes “beyond nicotine”
Stocks and shares

Philip Morris goes “beyond nicotine”

US tobacco giant Philip Morris International has agreed to pay £1bn for British inhaler specialist Vectura.
23 Jul 2021

Most Popular

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Why the UK's 2.5% inflation is a big deal
Inflation

Why the UK's 2.5% inflation is a big deal

After years of inflation being a financial-assets problem, it is now an “ordinary things” problem too, says Merryn Somerset Webb. But central banks st…
16 Jul 2021
Commodity supercycle or not, here’s a metal that’ll still be in demand – tin
Industrial metals

Commodity supercycle or not, here’s a metal that’ll still be in demand – tin

Commodity prices may have come off the boil recently. But for tin, the only way is up. Dominic Frisby picks the best ways to invest.
7 Jul 2021